Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
884 studies found for:    "Hypercholesterolemia"
Show Display Options
RSS Create an RSS feed from your search for:
"Hypercholesterolemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
2 Completed Polish Survey on the Efficacy of the Hypercholesterolemia Treatment
Condition: Hypercholesterolemia
Intervention:
3 Terminated Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: Placebo
4 Terminated Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: 25 mg/day AVE5530;   Drug: 50 mg/day AVE5530;   Drug: placebo
5 Completed A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)
Condition: Hypercholesterolemia
Interventions: Drug: MK0653A, ezetimibe (+) simvastatin;   Drug: Comparators: simvastatin and ezetimibe
6 Completed An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)
Condition: Hypercholesterolemia
Intervention: Drug: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 14 weeks
7 Terminated Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: atorvastatin;   Drug: placebo
8 Completed
Has Results
A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)
Condition: Hypercholesterolemia
Interventions: Drug: ezetimibe;   Drug: Comparator: placebo
9 Completed An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
10 Unknown  Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: vitamin D3 tablets;   Drug: placebo tablets
11 Completed Pan-European Survey on the Under Treatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
12 Completed Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
13 Completed Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf States
Condition: Hypercholesterolemia
Intervention:
14 Completed
Has Results
Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)
Condition: Primary Hypercholesterolemia
Interventions: Drug: ezetimibe;   Drug: Placebo
15 Completed Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
16 Completed A Study on the Effects of Soy Protein on Blood Lipids in Men and Women With Mild to Moderate Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Soy protein; 25 grams/day;   Dietary Supplement: Control protein
17 Completed Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia
Condition: Undertreatment of Hypercholesterolaemia
Intervention:
18 Completed A Study of LY3015014 in Participants With High Cholesterol
Condition: Hypercholesterolemia
Interventions: Drug: LY3015014;   Drug: Placebo
19 Completed Systematic Management of High Cholesterol Utilizing Computer Monitoring
Condition: Hypercholesterolemia
Interventions: Drug: Simvastin;   Procedure: Computer-based decision support technology
20 Completed Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: LGT209;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.